CNS Pharmaceuticals ( NASDAQ: CNSP ) on Friday filed a prospectus relating to the resale by selling shareholders from time to time of up to 2.36M shares of common stock issuable upon exercise of outstanding common stock purchase warrants issued to the selling shareholders. The company expects to receive proceeds of up to $4.
4M upon cash exercise of warrants. The company added that the preliminary prospectus is not an offer to sell. SEC Filing.
More on CNS Pharmaceuticals CNS Pharmaceuticals announces pricing of registered direct offering and concurrent private placement CNS Pharmaceuticals drops 6%, prices $1.37M offering Financial information for CNS Pharmaceuticals.
